We are live on ! Find out more
UCFA

United Capital Financial Advisors Portfolio holdings

AUM $16.3B
1-Year Est. Return 16.34%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+16.34%
3 Year Est. Return
+50.9%
5 Year Est. Return
+56.38%
10 Year Est. Return
+226.98%
AUM
$14.3B
AUM Growth
-$998M
Cap. Flow
-$1.18B
Cap. Flow %
-8.24%
Top 10 Hldgs %
23.59%
Holding
1,565
New
103
Increased
382
Reduced
744
Closed
257

Sector Composition

Rank Sector Weight
1 Technology 8.66%
2 Financials 6.31%
3 Healthcare 5.82%
4 Industrials 5.47%
5 Consumer Discretionary 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTOO
1276
DELISTED
T2 Biosystems, Inc
TTOO
$25K ﹤0.01%
2
IEAWW
1277
DELISTED
Infrastructure and Energy Alternatives, Inc. Warrant
IEAWW
$25K ﹤0.01%
619,608
+100,000
+19% +$3.41K
IGM icon
1278
iShares Expanded Tech Sector ETF
IGM
$10.7B
$24K ﹤0.01%
+666
New +$24.4K
MDR
1279
DELISTED
McDermott International
MDR
$24K ﹤0.01%
11,812
-574
-5% -$3.53K
BTE icon
1280
Baytex Energy
BTE
$3.08B
$23K ﹤0.01%
15,700
+500
+3% +$717
AMPE
1281
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$23K ﹤0.01%
155
+41
+36% +$5.46K
BAC.PRL icon
1282
Bank of America Series L
BAC.PRL
$4B
$22K ﹤0.01%
+15
New +$21.4K
SWN
1283
DELISTED
Southwestern Energy Company
SWN
$20K ﹤0.01%
10,159
-3,872
-28% -$8.31K
EYPT icon
1284
EyePoint Inc
EYPT
$1.13B
$18K ﹤0.01%
1,000
GHC icon
1285
Graham Holdings Company
GHC
$4.97B
$15K ﹤0.01%
+23
New +$16.3K
BIO icon
1286
Bio-Rad Laboratories Class A
BIO
$9.53B
$14K ﹤0.01%
+42
New +$13.7K
EG icon
1287
Everest Group
EG
$14B
$13K ﹤0.01%
+47
New +$11.9K
EVOK
1288
DELISTED
Evoke Pharma
EVOK
$13K ﹤0.01%
108
ONEQ icon
1289
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.8B
$13K ﹤0.01%
+400
New +$12.7K
FELP
1290
DELISTED
Foresight Energy LP
FELP
$13K ﹤0.01%
43,331
FBGX
1291
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$12K ﹤0.01%
+43
New +$12K
NTRP icon
1292
NextTrip
NTRP
$23.1M
$11K ﹤0.01%
75
GMO
1293
DELISTED
General Moly, Inc.
GMO
$10K ﹤0.01%
39,900
BURL icon
1294
Burlington
BURL
$22.6B
$8K ﹤0.01%
+40
New +$7.36K
DARE icon
1295
Dare Bioscience
DARE
$21.6M
$8K ﹤0.01%
854
UHAL icon
1296
U-Haul Holding Co
UHAL
$14.3B
$8K ﹤0.01%
+210
New +$7.76K
ASXC
1297
DELISTED
Asensus Surgical, Inc.
ASXC
$8K ﹤0.01%
1,000
+77
+8% +$1.05K
CHE icon
1298
Chemed
CHE
$7.02B
$6K ﹤0.01%
+14
New +$5.71K
IHI icon
1299
iShares US Medical Devices ETF
IHI
$3.47B
$4K ﹤0.01%
+108
New +$4.42K
WCG
1300
DELISTED
Wellcare Health Plans, Inc.
WCG
$4K ﹤0.01%
+17
New +$4.69K

Similar funds

United Capital Financial Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, United Capital Financial Advisors held 1,565 positions worth $14.3B, down 6.5% from $15.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

United Capital Financial Advisors withdrew a net $1.18B in Q3 2019, closing 257 positions and reducing 744 holdings. Its most notable exit was Vanguard Long-Term Treasury ETF, an estimated $10.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, United Capital Financial Advisors opened a new position in Factset worth $7.01M.

  • United Capital Financial Advisors's largest Q3 2019 buy was Factset: 28,858 shares worth $7.01M.
  • United Capital Financial Advisors added most to Altria Group in Q3 2019, an estimated $39.7M increase.
  • United Capital Financial Advisors's biggest Q3 2019 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $237M.
  • United Capital Financial Advisors fully exited Vanguard Long-Term Treasury ETF in Q3 2019, selling an estimated $10.6M.
  • United Capital Financial Advisors's ten largest holdings make up 24% of its $14.3B portfolio in Q3 2019.
  • United Capital Financial Advisors opened 103 new positions and closed 257 in Q3 2019.
  • United Capital Financial Advisors's portfolio value fell 6.5% quarter-over-quarter to $14.3B.

Based on United Capital Financial Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.